Three to tang : MUC1 as a ligand for both E-selectin and ICAM-1 in the breast cancer metastatic cascade

被引:41
作者
Geng, Yue [1 ]
Yeh, Kimberly [1 ]
Takatani, Tait [1 ]
King, Michael R. [1 ]
机构
[1] Cornell Univ, Dept Biomed Engn, 205 Weill Hall, Ithaca, NY 14853 USA
来源
FRONTIERS IN ONCOLOGY | 2012年 / 2卷
关键词
adhesion; breast cancer; circulation; E-selectin; ICAM-1; MUC1;
D O I
10.2389/fonc.2012.00076
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer cell tethering and rolling on the vascular wall is facilitated by various selectin: glycoprotein interactions which lead to eventual extravasation and metastases. The aberrantly underglycosylated mucin MUC1 has been shown to both abundantly express selectin binding moieties (sialyl Lewis x and a) and to consistently expose its core epitope. Flow cytometry was used to determine MUC1 expression on ZR-75-1 and MCF7 cells, while immunofluorescence microscopy was used to confirm the aberrant form of MUC1 and MUC1:ICAM-1 interactions. Each cell line was then perfused through combined E-selectin and ICAM-1 coated microtubes, as a model of the microvascular endothelium. ZR-75-1 and MCF7 were found to express abundant and low levels of underglycosylated MUC1, respectively. The rolling/adhesion profiles showed that ZR-75-1 cells, when compared to MCF7 cells, interact with E-selectin more efficiently resulting in sufficiently slow rolling velocities to form MUC1:ICAM-1 interactions thereby facilitating firm adhesion. The purpose and novelty of this work is the demonstration of the synergistic adhesion capabilities of MUC1 in the metastatic adhesion cascade, where the observed differential adhesion is consistent with the relative metastatic potential of the ZR-75-1 (highly metastatic) and MCF7 (weakly metastatic) cell lines.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 35 条
  • [1] Significance of MUC1 and MUC2 mucin expression in colorectal cancer
    Ajioka, Y
    Allison, LJ
    Jass, JR
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (07) : 560 - 564
  • [2] Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis
    Borsig, L
    Wong, R
    Hynes, RO
    Varki, NM
    Varki, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) : 2193 - 2198
  • [3] Oligosaccharides expressed an MUC1 produced by pancreatic and colon tumor cell lines
    Burdick, MD
    Harris, A
    Reid, CJ
    Iwamura, T
    Hollingsworth, MA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (39) : 24198 - 24202
  • [4] ICAM-1 (CD54) - A COUNTER-RECEPTOR FOR MAC-1 (CD11B CD18)
    DIAMOND, MS
    STAUNTON, DE
    DEFOUGEROLLES, AR
    STACKER, SA
    GARCIAAGUILAR, J
    HIBBS, ML
    SPRINGER, TA
    [J]. JOURNAL OF CELL BIOLOGY, 1990, 111 (06) : 3129 - 3139
  • [5] Ding ZM, 1999, J IMMUNOL, V163, P5029
  • [6] Crystal structure at 1.95 Å resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition
    Dokurno, P
    Bates, PA
    Band, HA
    Stewart, LMD
    Lally, JM
    Burchell, JM
    Taylor-Papadimitriou, J
    Snary, D
    Sternberg, MJE
    Freemont, PS
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1998, 284 (03) : 713 - 728
  • [7] The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer
    Duncan T.J.
    Watson N.F.S.
    Al-Attar A.H.
    Scholefield J.H.
    Durrant L.G.
    [J]. World Journal of Surgical Oncology, 5 (1)
  • [8] A SMOOTH PARTICLE MESH EWALD METHOD
    ESSMANN, U
    PERERA, L
    BERKOWITZ, ML
    DARDEN, T
    LEE, H
    PEDERSEN, LG
    [J]. JOURNAL OF CHEMICAL PHYSICS, 1995, 103 (19) : 8577 - 8593
  • [9] ICAM-1 supports adhesion of human small-cell lung carcinoma to endothelial cells
    Finzel, AH
    Reininger, AJ
    Bode, PA
    Wurzinger, LJ
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2004, 21 (03) : 185 - 189
  • [10] Glycomechanics of the Metastatic Cascade: Tumor Cell-Endothelial Cell Interactions in the Circulation
    Geng, Yue
    Marshall, Jocelyn R.
    King, Michael R.
    [J]. ANNALS OF BIOMEDICAL ENGINEERING, 2012, 40 (04) : 790 - 805